Pivotal trial cohort hits six-month milestone as FDA filings move forward
COCH Envoy Medical, Inc. Class A Common Stock
XNAS
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
COCH
—
—
What changed
Recent filings, trades and moves- Nov 5 8-K: Earnings results
- Nov 5 Quarterly report (10-Q) filed
Key stats
Related
About
- Industry (SIC)
- ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES (3842) · industry map
- Exchange
- XNAS
- Market Cap
- $0.1B
- Employees
- 47
- List Date
- 2023-10-02
- CIK
- 0001840877
- Last Earnings
- Aug 13 · +6.7%
- Headquarters
- White Bear Lake, MN
- Homepage
- https://www.envoymedical.com
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|
| Jan | -- | -38.62% | 7.79% | -6.58% | -12.47% |
| Feb | -- | 292.50% | -17.96% | 11.45% | 95.33% |
| Mar | -- | -37.28% | -2.26% | -4.90% | -14.81% |
| Apr | -- | -3.41% | 8.40% | -3.55% | 0.48% |
| May | -- | -46.50% | 10.20% | 3.60% | -10.90% |
| Jun | -- | 0.85% | -5.33% | 13.14% | 2.89% |
| Jul | -- | -10.08% | -2.01% | -15.12% | -9.07% |
| Aug | -- | 31.30% | -14.88% | 5.58% | 7.33% |
| Sep | -- | -2.40% | -39.87% | -3.31% | -15.19% |
| Oct | -74.58% | -0.75% | 4.07% | 0.36% | -17.72% |
| Nov | 80.00% | -10.59% | 9.89% | 8.12%* | 21.86% |
| Dec | -21.96% | -36.73% | -18.38% | -- | -25.69% |
| Total | -64.29% | -49.05% | -54.24% | 5.25% | -40.58% |
* Only 4 year(s) of data available.
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $6.60
SMA 50: $6.82
SMA 200: $6.88
Current: $7.19
EMA 12: $6.83
EMA 26: $6.74
MACD: 0.0899 | Signal: 0.1094
BEARISH
ADX (14): 32.11
TREND
+DI: 16.32
−DI: 17.92
Momentum Oscillators
RSI (14): 61.94
NEUTRAL
Stoch %K: 88.56
Stoch %D: 87.05
Williams %R: -9.86
Volume & Volatility
BB Upper: $7.26
BB Lower: $5.94
NEUTRAL
OBV: 17,860,966
Vol SMA 20: 26,920
Vol ROC: -76.09%
ATR: $0.53
True Range: $0.26
HV 20: 58.0%
HV 30: 52.2%
HV 60: 51.0%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-11-08T00:00:00 – 2026-11-06T00:00:00
AI Analysis
Click Frenzy-Pro™ for an AI analysis of this ticker.
Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.
News
All COCH news →
Earnings History
1 of 1 under expected move
Avg Expected Move
—
Avg Actual Move
7.20%
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2026-08-13 | unknown | — | 7.20% | — | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
COCH Options Activity & IV Rank
Loading options activity...
Spread Scanner
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Calendars: the long leg is valued at the short leg’s expiration (Black-Scholes at its current IV) across the range of prices the short leg’s IV implies, giving the best-case profit (R/R = that over the debit) and P(profit).
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Scanning bull put, bear call, iron condor and calendar spreads…
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
30 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Loading the implied volatility surface…
Volatility Smile
Loading the implied volatility smile…
IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Risk Metrics
Beta: 1.2506
Alpha: 31.04%
Correlation: 0.1689
R-Squared: 2.9%
Stock Volatility: 102.0%
Market Volatility: 13.8%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
High volatility - stock moves more than market
High volatility - stock moves more than market
Beta & Alpha Over Time
Notable investors who own COCH
1 of 37 tracked investors
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Rockefeller Capital Management Family office Rockefeller family | $2K | #4403 of 4729 | 0.0% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
COCH Institutional Ownership (13F)
Filings for 2026-06-30 · 11 already for 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
COCH Insider Trading (Form 4)
Latest: 2026-08-26Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-08-26 | Robert Potashnick | CAO & VP of Finance | Award (A) | — | — | EDGAR | |
| 2026-06-23 | Brent T. Lucas | Chief Executive Officer | Award (A) | — | — | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
COCH Insider Holdings
2 insiders · @ $7.19
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Brent T. Lucas | Chief Executive Officer | 32,995 | $237.2K | $0 | 1 | 2026-06-23 |
| 2 | Robert Potashnick | CAO & VP of Finance | 21,250 | $152.8K | $0 | 1 | 2026-08-26 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
COCH Board & Officers
As of SEC filings through Aug 26, 2026Directors 8
- Susan Kantor · since Mar 1, 2021
- Brent T. Lucas · since Sep 29, 2023
- Charles Brynelsen · since Sep 29, 2023
- Glen A Taylor · since Sep 29, 2023
- Janis Smith-Gomez · since Sep 29, 2023
- Mona Chetan Patel · since Sep 29, 2023
- Michael Curtis Crowe · since Jun 7, 2024
- Chas McKhann · since Apr 15, 2026
Officers 2
- Brent T. Lucas · Chief Executive Officer · since Sep 29, 2023
- Robert Potashnick · Interim CFO · since Jun 23, 2025
10% owners 1
- Glen A Taylor · since Sep 29, 2023
Changes in the last 10 years (37)
| Apr 15, 2026 | Chas McKhann became a director |
| Jun 23, 2025 | Robert Potashnick became Interim CFO |
| Jun 7, 2024 | Michael Curtis Crowe became a director |
| Oct 3, 2023 | Priya Cherian Huskins reported in an SEC filing no longer being a director |
| Oct 3, 2023 | Diane L Dewbrey reported in an SEC filing no longer being a director |
| Oct 3, 2023 | Daniel J. Hirsch reported in an SEC filing no longer being a director |
| Oct 3, 2023 | Daniel J. Hirsch reported in an SEC filing no longer being CFO and Corporate Secretary |
| Sep 29, 2023 | The company announced the departure of Whitney Haring-Smith from the board in an SEC filing |
| Sep 29, 2023 | The company announced the departure of Whitney Haring-Smith as Chief Executive Officer in an SEC filing |
| Sep 29, 2023 | Mona Chetan Patel became a director |
| Sep 29, 2023 | Janis Smith-Gomez became a director |
| Sep 29, 2023 | Glen A Taylor became a director |
| Sep 29, 2023 | Glen A Taylor became a 10% owner |
| Sep 29, 2023 | David R. Wells became Chief Financial Officer |
| Sep 29, 2023 | Charles Brynelsen became a director |
| Sep 29, 2023 | Brent T. Lucas became a director |
| Sep 29, 2023 | Brent T. Lucas became Chief Executive Officer |
| Mar 31, 2023 | Barclays Plc reported in an SEC filing no longer being a 10% owner |
| Mar 6, 2023 | Barclays Plc became a 10% owner |
| Mar 2, 2023 | Atlas Merchant Capital LLC became a 10% owner |
| Oct 4, 2022 | Whitney Haring-Smith first listed as a 10% owner in an SEC filing |
| Oct 1, 2022 | Diane L Dewbrey became a director |
| Oct 1, 2022 | Daniel J. Hirsch became a director |
| Oct 1, 2022 | Daniel J. Hirsch became CFO and Corporate Secretary |
| Jul 31, 2022 | The company announced the departure of William A Wulfsohn from the board in an SEC filing |
| Jul 29, 2022 | The company announced the departure of Teresa A Harris from the board in an SEC filing |
| Jul 29, 2022 | The company announced the departure of Peter Ganz as GC and Corporate Secretary in an SEC filing |
| Jul 29, 2022 | The company announced the departure of John W. Joy as Chief Financial Officer in an SEC filing |
| Mar 1, 2021 | William A Wulfsohn became a director |
| Mar 1, 2021 | Whitney Haring-Smith became a director |
| Mar 1, 2021 | Whitney Haring-Smith became Chief Executive Officer |
| Mar 1, 2021 | Teresa A Harris became a director |
| Mar 1, 2021 | Susan Kantor became a director |
| Mar 1, 2021 | Priya Cherian Huskins became a director |
| Mar 1, 2021 | Peter Ganz became GC and Corporate Secretary |
| Mar 1, 2021 | John W. Joy became Chief Financial Officer |
| Mar 1, 2021 | Anzu SPAC GP I LLC became a 10% owner |
Not reported recently (4)
- Anzu SPAC GP I LLC · Last reported as a 10% owner in an SEC filing dated Dec 26, 2024
- Whitney Haring-Smith · Last reported as a 10% owner in an SEC filing dated Dec 26, 2024
- David R. Wells · Last reported as Chief Financial Officer in an SEC filing dated Oct 17, 2023
- Atlas Merchant Capital LLC · Last reported as a 10% owner in an SEC filing dated Mar 13, 2023
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
Recent SEC Filings
Latest: 2026-11-05
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
| Filing Date | Event | Link |
|---|---|---|
| 2026-11-05 | Earnings results | EDGAR |
| 2026-10-27 | Shareholder rights change · Bylaws or fiscal year change · Regulation FD disclosure | EDGAR |
| 2026-10-16 | Shareholder vote results | EDGAR |
| 2026-10-07 | Other events | EDGAR |
| 2026-08-27 | Director or officer change | EDGAR |
| 2026-08-10 | Earnings results | EDGAR |
| 2026-06-30 | Agreement terminated | EDGAR |
| 2026-06-25 | Director or officer change | EDGAR |
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
| Filing Date | Accession | Link |
|---|
ETF Holders
2 ETFs hold COCH
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
COCH vs Peers
Related companies, largest first| Company | Market cap | P/E | Revenue growth | YTD | IV rank |
|---|---|---|---|---|---|
| ISRG Intuitive Surgical Inc. | $160.0B | 55.7 | +20.5% | −18.0% | 17 |
| EW Edwards Lifesciences Corp | $58.7B | 60.5 | +14.6% | +23.3% | 17 |
| STE STERIS plc | $24.5B | 30.7 | +8.1% | +3.3% | 31 |
| ZBH Zimmer Biomet Holdings, Inc. | $20.0B | 26.5 | +8.6% | +21.2% | 9 |
| SNN Smith & Nephew plc | $13.0B | — | — | −5.3% | 33 |
| ALGN Align Technology Inc | $11.7B | 30.7 | +4.4% | +13.0% | 14 |
| MSA Mine Safety Incorporated | $6.6B | 22.3 | +8.1% | +7.2% | 46 |
| ESTA Establishment Labs Holdings Inc. | $2.0B | — | +34.9% | −1.3% | 49 |
| COCH Envoy Medical, Inc. Class A Common Stock | $55M | — | — | +3.3% | — |
| Peer median | $16.5B | 30.7 | +8.6% | +5.2% | 24 |
P/E uses the latest reported trailing-12-month diluted EPS; "—" means no positive earnings or no data.